Exploring the latest data on treatment options for patients with PD-L1 <1% metastatic and resectable non-metastatic NSCLC1.
This program is not CME accredited.
This event has ended.
Thank you to those who were able to join us.
- November 14, 2024
- 6:30 PM EST - 7:30 PM EST
- 1 Hour
